25 March 2026International Conference on Alzheimer’s and Parkinson’s Disease AD/PD 2026 in CopenhagenRead more
03 March 2026Advancing Huntington’s Disease Research: Harness at the 21st Annual CHDI Foundation Therapeutics ConferenceRead more
16 February 2026Harness Therapeutics Nominates HRN001, a First-in-Class Drug Candidate for Huntington’s Disease and Establishes Clinical Advisory BoardRead more
05 February 2026CHDI Foundation's Annual Huntington’s Disease Therapeutics Conference in Palm SpringsRead more
February 2026Harness Therapeutics Nominates HRN001, a First-in-Class Drug Candidate for Huntington’s Disease and Establishes Clinical Advisory BoardRead more
October 2025Harness Therapeutics Announces Launch of MISBA® Duo Platform and Research Collaboration with Ono Venture InvestmentRead more
February 2025Harness Therapeutics to Present Nanopore Sequencing Data for Detecting CAG Expansion in the Huntingtin Gene at CHDI Huntington’s Disease Therapeutics ConferenceRead more